Literature DB >> 10698188

Two putative GATA motifs in the proximal exon 1 promoter of the rat insulin-like growth factor I gene regulate basal promoter activity.

L Wang1, X Wang, M L Adamo.   

Abstract

The insulin-like growth factor I gene is transcribed from two promoters, which direct synthesis of alternative first exons (exon 1 and exon 2) in insulin-like growth factor I messenger RNAs (mRNAs). An exon 1 promoter construct extending from +75 to +192 (the most upstream exon 1 start site was designated as +1) showed significant promoter activity in C6, OVCAR-3, and SK-N-MC cells. Within the +75 to +192 region, there are two perfect matches to the consensus binding site for GATA transcription factor, at +108 (GATA-A) and at +183 (GATA-B). Mutations of the GATA-A or GATA-B sequences resulted in slight (or no) effect on exon 1 promoter activity in both C6 and OVCAR-3 cells. However, mutation of the GATA-A sequence stimulated exon 1 promoter activity by 68% in SK-N-MC cells. Mutation of the GATA-B sequence inhibited exon 1 promoter activity by 4.4-fold in SK-N-MC cells. Electrophoretic mobility shift assays showed that there were nuclear proteins in SK-N-MC cells capable of specifically binding to the GATA-A and GATA-B elements and that this binding was GATA-sequence specific. GATA-2, GATA-3, and GATA-4 are the only GATA proteins that have been reported to be expressed in neurons. None of the antibodies against these three GATA proteins were capable of inhibiting or supershifting the bands formed by the nuclear proteins and oligonucleotides containing GATA-A or GATA-B elements. A GATA-1 expression vector was used to perform cotransfection experiments. The GATA-A mutation abolished the stimulatory effect of the GATA-1 factor on promoter activity. In contrast, the GATA-B mutation enhanced the stimulatory effect of GATA-1 protein. Anti-GATA-1 antibody was also incapable of inhibiting or supershifting the bands formed by the nuclear proteins and oligonucleotides containing the GATA-A or GATA-B elements. In conclusion, the GATA-A element seems to bind an inhibitory endogenous factor(s) in SK-N-MC cells, whereas the GATA-B element may bind a stimulatory factor(s). These factors seem to be related to GATA transcription factors but are immunologically distinct from GATA-2, GATA-3, or GATA-4. GATA-1 has the potential to transactivate the exon 1 promoter through the GATA-A element but is unlikely to be the endogenous protein binding to the GATA-A or the GATA-B motifs in SK-N-MC cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698188     DOI: 10.1210/endo.141.3.7344

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.

Authors:  Aldona Kasprzak; Agnieszka Adamek; Wiesława Przybyszewska; Przemysław Pyda; Jacek Szmeja; Agnieszka Seraszek-Jaros; Agata Lanzafame; Anna Surdacka; Iwona Mozer-Lisewska; Maria Koczorowska
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

2.  GATA depletion impacts insulin-like growth factor 1 mRNA and protein levels in luteinizing porcine granulosa cells.

Authors:  Holly A LaVoie; Richard J Kordus; Jonathan B Nguyen; Jeremy L Barth; Yvonne Y Hui
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

3.  GATA4 and GATA6 regulate intestinal epithelial cytodifferentiation during development.

Authors:  Emily M Walker; Cayla A Thompson; Michele A Battle
Journal:  Dev Biol       Date:  2014-06-12       Impact factor: 3.582

4.  Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.

Authors:  Shoshana Yakar; Clifford J Rosen; Mary L Bouxsein; Hui Sun; Wilson Mejia; Yuki Kawashima; Yingjie Wu; Kelly Emerton; Valerie Williams; Karl Jepsen; Mitchell B Schaffler; Robert J Majeska; Oksana Gavrilova; Mariana Gutierrez; David Hwang; Patricia Pennisi; Jan Frystyk; Yves Boisclair; John Pintar; Héctor Jasper; Horacio Domene; Pinchas Cohen; David Clemmons; Derek LeRoith
Journal:  FASEB J       Date:  2008-10-24       Impact factor: 5.191

Review 5.  Gene regulation by growth hormone.

Authors:  Peter Rotwein; Dennis J Chia
Journal:  Pediatr Nephrol       Date:  2009-07-22       Impact factor: 3.714

6.  Evaluation of the microsomal glutathione S-transferase 3 (MGST3) locus on 1q23 as a Type 2 diabetes susceptibility gene in Pima Indians.

Authors:  Farook Thameem; Xiaolin Yang; Paska A Permana; Johanna K Wolford; Clifton Bogardus; Michal Prochazka
Journal:  Hum Genet       Date:  2003-07-26       Impact factor: 4.132

Review 7.  Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system.

Authors:  Joachim Woelfle; Dennis J Chia; Mylynda B Massart-Schlesinger; Paula Moyano; Peter Rotwein
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

8.  A microsatellite polymorphism in IGF1 gene promoter and timing of natural menopause in Caucasian women.

Authors:  Maria Kaczmarek; Joanna Pacholska-Bogalska; Wojciech Kwaśniewski; Jan Kotarski; Barbara Halerz-Nowakowska; Anna Goździka-Józefiak
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

9.  The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging.

Authors:  A M Oberbauer
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-26       Impact factor: 5.555

Review 10.  Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?

Authors:  Mamneet Manghera; Renée N Douville
Journal:  Retrovirology       Date:  2013-02-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.